Shanghai Pharmaceuticals Holding Co Ltd (601607) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.017x

Based on the latest financial reports, Shanghai Pharmaceuticals Holding Co Ltd (601607) has a cash flow conversion efficiency ratio of 0.017x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥1.56 Billion) by net assets (CN¥89.62 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Shanghai Pharmaceuticals Holding Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Shanghai Pharmaceuticals Holding Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Shanghai Pharmaceuticals Holding Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Pharmaceuticals Holding Co Ltd ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Shanghai Pharmaceuticals Holding Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai Pharmaceuticals Holding Co Ltd from 1998 to 2025.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥89.79 Billion CN¥6.15 Billion 0.069x -1.50%
2024-12-31 CN¥83.74 Billion CN¥5.83 Billion 0.070x +6.84%
2023-12-31 CN¥80.33 Billion CN¥5.23 Billion 0.065x +7.10%
2022-12-31 CN¥78.00 Billion CN¥4.74 Billion 0.061x -29.03%
2021-12-31 CN¥59.07 Billion CN¥5.06 Billion 0.086x -31.47%
2020-12-31 CN¥54.74 Billion CN¥6.84 Billion 0.125x +2.54%
2019-12-31 CN¥49.39 Billion CN¥6.02 Billion 0.122x +80.61%
2018-12-31 CN¥46.43 Billion CN¥3.14 Billion 0.068x +1.13%
2017-12-31 CN¥39.68 Billion CN¥2.65 Billion 0.067x +26.32%
2016-12-31 CN¥36.83 Billion CN¥1.95 Billion 0.053x +32.43%
2015-12-31 CN¥33.81 Billion CN¥1.35 Billion 0.040x -7.08%
2014-12-31 CN¥31.10 Billion CN¥1.34 Billion 0.043x +27.95%
2013-12-31 CN¥29.00 Billion CN¥973.45 Million 0.034x -19.20%
2012-12-31 CN¥27.70 Billion CN¥1.15 Billion 0.042x -39.10%
2011-12-31 CN¥25.98 Billion CN¥1.77 Billion 0.068x -51.92%
2010-12-31 CN¥11.88 Billion CN¥1.69 Billion 0.142x -50.39%
2009-12-31 CN¥2.32 Billion CN¥664.13 Million 0.286x +109.19%
2008-12-31 CN¥2.09 Billion CN¥285.68 Million 0.137x -45.25%
2007-12-31 CN¥1.96 Billion CN¥488.94 Million 0.250x -11.50%
2006-12-31 CN¥2.07 Billion CN¥583.11 Million 0.282x +675.17%
2005-12-31 CN¥2.01 Billion CN¥73.00 Million 0.036x +21.65%
2004-12-31 CN¥2.06 Billion CN¥61.66 Million 0.030x +13043.04%
2003-12-31 CN¥2.13 Billion CN¥484.27K 0.000x -99.55%
2002-12-31 CN¥2.00 Billion CN¥100.84 Million 0.050x +39.50%
2001-12-31 CN¥1.82 Billion CN¥65.73 Million 0.036x -75.64%
2000-12-31 CN¥985.30 Million CN¥146.22 Million 0.148x -23.41%
1999-12-31 CN¥849.92 Million CN¥164.67 Million 0.194x +148.82%
1998-12-31 CN¥713.42 Million CN¥-283.14 Million -0.397x --

About Shanghai Pharmaceuticals Holding Co Ltd

SHG:601607 China Medical Distribution
Market Cap
$6.93 Billion
CN¥47.39 Billion CNY
Market Cap Rank
#2698 Global
#329 in China
Share Price
CN¥16.99
Change (1 day)
-0.88%
52-Week Range
CN¥16.30 - CN¥19.48
All Time High
CN¥25.03
About

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric … Read more